Abstract:Despite significant advances, cancer remains a leading global cause of death. Current therapies often fail due to incomplete tumor removal and nonspecific targeting, spurring interest in alternative treatments. Hyperthermia, which uses elevated temperatures to kill cancer cells or boost their sensitivity to radio/chemotherapy, has emerged as a promising alternative. Recent advancements employ nanoparticles (NPs) as heat mediators for selective cancer cell destruction, minimizing damage to healthy tissues. This approach, known as NP hyperthermia, falls into two categories: photothermal therapies (PTT) and magnetothermal therapies (MTT). PTT utilizes NPs that convert light to heat, while MTT uses magnetic NPs activated by alternating magnetic fields (AMF), both achieving localized tumor damage. These methods offer advantages like precise targeting, minimal invasiveness, and reduced systemic toxicity. However, the efficacy of NP hyperthermia depends on many factors, in particular, the NP properties, the tumor microenvironment (TME), and TME-NP interactions. Optimizing this treatment requires accurate heat monitoring strategies, such as nanothermometry and biologically relevant screening models that can better mimic the physiological features of the tumor in the human body. This review explores the state-of-the-art in NP-mediated cancer hyperthermia, discussing available nanomaterials, their strengths and weaknesses, characterization methods, and future directions. Our particular focus lies in preclinical NP screening techniques, providing an updated perspective on their efficacy and relevance in the journey towards clinical trials.

Progress of translational medicine in the tumor thermotherapy and tumor immunology

Translational Prospects of Ultrasound-Mediated Tumor Immunotherapy: A Review of Preclinical Advances and Safety Considerations.

Tumor Treatment Based on Translational Medicine

Research progress on tumor hyperthermia

Molecular Imaging-Guided Interventional Hyperthermia in Treatment of Breast Cancer.

Progress in Anticancer Immunities by Hyperthermia

Progress of Hyperthermia in Tumor Treatment

Progress of Combination Therapy for Tumor Comprising Hyperthermia with Dendritic Cells

Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy

Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia

Research Progress on the Mechanism of Anti-Tumor Immune Response Induced by TTFields

Research Progress of Nanomedicine-Based Mild Photothermal Therapy in Tumor

Role of tumor microenvironment in cancer progression and therapeutic strategy

Progress in functional composite biomaterials for local tumor thermal therapy

Thermal immuno-nanomedicine in cancer

Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells

Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors

Research advances of traditional Chinese medicine in cancer immunotherapy

Nanoparticle-mediated thermal Cancer therapies: Strategies to improve clinical translatability

Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition

Tumor Immune Escape and Localized Hyperthermia Ablation